Frontiers in Pharmacology · 2019 · 101 citations · 16 references
Life SciencesMicrobiologyNutritionClinical NutritionMicrobial MetabolismMicrobiome ResearchGut MicrobiomeGut MicrobiotaMetabolic SyndromeMicrobiome BiomarkersMicrobiome CompositionMicrobiome DysbiosisGut Microbiome DiversityGut Microbiome DysbiosisGut Microbiota CompositionGut Microbiota DysbiosisGut Microbiota EffectsMetabolic Syndrome DysbiosisMicrobiome-associated MetabolitesMicrobiota-derived Metabolites
Background: Metabolic syndrome (MS) is one of the major cause of cardiovascular diseases(CAD). Gut microbiome diversity and its natural fermentation products are not only correlated with MS and CAD but also appear to be stronger than the associations of traditional risk factors. Therefore, the aim of this study was to provide a new potential pathway for natural fermentation product butyrate to improve metabolic syndrome and to examine whether associated with the serum metabolic profiles and gut flora composition. Method: C57BL/6 mice fed a high-fat diet were treated with 400mg/kg of sodium butyrate for 16 weeks. Blood and fecal samples were collected and measured with LC-MS and Illumina platform. The plasma differential metabolites and gut microbiome composition were analyzed with XCMS online and QIIME 2. Results: Gut microbiome-derived butyrate improved glucose intolerance and insulin resistance, resisting high-fat diet(HFD)-induced an increase of the relative abundance of f_Lachnospiracease, f_Rikenellaceae, and f_Paraprevotellaceae. Meanwhile, sodium butyrate increased the levels of α-linolenate, all-trans-retinal, resolvin E1, and leukotriene in the plasma and the differential pathways were mainly enrichment in resolvin E biosynthesis, histidine degradation, lipoxin biosynthesis, and leukotriene biosynthesis. Moreover, sodium butyrate can increase the levels of phosphorylated-adenosine 5‘-monophosphate (AMP)-activated protein kinas (p-AMPK) and facilitated glucose transporter member 4 (GLUT4) in adipose tissue. Conclusion: Butyrate can induce AMPK activation and GLUT4 expression in the adipose, improving cardiovascular disease-related metabolic disorder, resisting HFD- induced gut microbiome dysbiosis, and promoting resolvin E and lipoxin biosynthesis. Oral supplement of natural fermentation product butyrate can be a potential strategy for preventing cardiovascular diseases. KEYWORDS: AMPK, GLUT-4, Metabolomics, Sodium butyrate, 16s rRNA sequencing
16
Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice
Zhan‐Guo Gao, Jun Yin, Jin Zhang et al. · Diabetes · 2009 · 2.2K citations · Full text
Acetate mediates a microbiome–brain–β-cell axis to promote metabolic syndrome
Rachel J. Perry, Liang Peng, Natasha A. Barry et al. · Nature · 2016 · 1.3K citations